307
Participants
Start Date
May 31, 2009
Primary Completion Date
April 30, 2010
Study Completion Date
July 31, 2010
GS-9450
Taken as one capsule by mouth once daily
Placebo
Taken as one placebo capsule (matching in appearance to GS-9450 capsules) by mouth once daily
Phoenix
Tucson
Anaheim
Beverly Hills
Cypress
La Jolla
Mission Hills
Palm Springs
Pasadena
San Clemente
San Diego
Washington D.C.
Hialeah
Miami
North Miami Beach
Orlando
Sarasota
Tampa
Decatur
Chicago
Indianapolis
Louisville
Baton Rouge
New Orleans
Annapolis
Baltimore
Boston
Novi
Saint Louis
Plymouth
Omaha
Las Vegas
Hillsborough
Morristown
Santa Fe
Johnson City
New York
Plainview
Cincinnati
Cleveland
Philadelphia
Providence
Chattanooga
Germantown
Dallas
San Antonio
Fairfax
Falls Church
Norfolk
Seattle
Madison
Vancouver
Winnipeg
London
Berlin
Bonn
Cologne
Essen
Frankfurt am Main
Hamburg
Hanover
Mainz
Bialystok
Bydgoszcz
Chorzów
Kielce
Wroclaw
San Juan
Santurce
Brighton
London
Nottingham
Sheffield
Lead Sponsor
Gilead Sciences
INDUSTRY